SK Chemicals Co Ltd (285130) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of SK Chemicals Co Ltd KRW 87,948, price KRW 51,800, upside +69.8%, quality 39 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch SK Chemicals Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
SK Chemicals Co.,Ltd provides chemicals and life sciences products and solutions in South Korea, China, Japan, Asia, the United States, Europe, and internationally.
Show more
SK Chemicals Co.,Ltd provides chemicals and life sciences products and solutions in South Korea, China, Japan, Asia, the United States, Europe, and internationally. The company offers copolyester, engineering plastic, petro chemical, specialty chemical, coating and adhesive, biomaterial, and performance chemical for covid-19 personal protective equipment, industrial materials, sustainable packaging solution, packaging, cosmetic, automotive, consumer goods and sports, and electronics and home appliance applications. It sells its products under the SKYGREEN, SKYPEL, SKYBON, ECOZEN, SKYTRA, ECOTRION, CLARO, SKYDMT, CnR, ECOTRIA, SKYCHDM, E.Chemical, SKYPET, SKYDMCD, SKYPURA, and SKYCHDA brands. The company provides ETC drugs, including musculoskeletal system, anti-inflammatory agents/analgenics, digestive system, central nervous system, respiratory system, urinary system, kidney/rheumatism, circulatory system/metabolic disease, antimicrobial/antiviral agents, and others; OTC drugs, such as common cold/antihistamine, drugs to improve blood flow, vitamins/minerals, dermatologicals, and other products. The company was founded in 1969 and is headquartered in Seongnam-si, South Korea.
Stock analysis
SK Chemicals Co Ltd (285130) currently trades at 51,800 KRW, while our model-based Fair Value estimate is 87,948 KRW, implying the stock looks roughly 41.1% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 111,325 KRW per share, and 6 of the 10 models we run sit above the 51,800 KRW price.
Bear case: the Multiples group reads lowest at 43,951 KRW, and 4 of the 10 models stay below the price. Evidence for this calculation is medium.
Scenario range: 77,927 KRW (bear) to 87,948 KRW (bull), the price of 51,800 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
SK Chemicals Co Ltd reported revenue of 2.4T KRW in FY2025 versus 2.1T KRW in FY2021, a compound +3.1%/yr. Reported net income was 44.6B KRW in FY2025, compounding −28.2%/yr from FY2021.
Key figures
Market cap 892B KRW (≈ $665M) · P/S ratio 0.32 · Dividend yield 1.4% · Net margin 1.9% · Return on equity −0.6% · Return on assets (EBIT) 4.2% · Operating margin −2.9% · Revenue (TTM) 2.5T KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 34% below its 52-week high and 39% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at 70%, 285130 screens cheaper than that median.
Fair Value models
Bear 77,927 KRWFair Value 87,948 KRWBull 87,948 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.44/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+36.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.3%
Start year 2020 (pandemic). Over 10 years: +8.6% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.1%
’14
’15
’16
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−21.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−23.0%
Dividend (yield on the price)1.4%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 0%
⚠ Revenue per share shrinking 2.5%/yr over ~6Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 693 stocks
Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score39 · Bottom 25%
Fair Value upside+187.0% · Top 25%
Profitability
Return on assets−0.5% · Bottom 25%
Net margin (TTM)0.5% · Bottom 25%
Operating margin (TTM)−2.9% · Bottom 25%
Growth and dividend
Revenue growth22.2% · Above median
Dividend yield (TTM)1.4% · Above median
Balance sheet
Debt / equity0.74× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "SK Chemicals Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/285130
Frequently asked questions
Is SK Chemicals Co Ltd (285130) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 87,948 KRW versus a price of 51,800 KRW, about +70% upside (undervalued).
What is the fair value of 285130?
Our model-based fair value for SK Chemicals Co Ltd is 87,948 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 51,800 KRW.
What is the quality score of 285130?
SK Chemicals Co Ltd has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for SK Chemicals Co Ltd (285130)?
Our model-based price target is the fair value of 87,948 KRW (as of Sep 24, 2026) from 10 valuation models. Cautious scenario 77,927 KRW, optimistic scenario 87,948 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the SK Chemicals Co Ltd stock forecast for 2026?
Our models put fair value at 87,948 KRW, about +70% upside versus a price of 51,800 KRW (undervalued). Cautious scenario 77,927 KRW, optimistic scenario 87,948 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of SK Chemicals Co Ltd (285130)?
SK Chemicals Co Ltd reported trailing-twelve-month revenue of about 2.5T KRW (latest available figure, as of Sep 24, 2026).
Does SK Chemicals Co Ltd pay a dividend?
SK Chemicals Co Ltd currently shows a dividend yield of about 1.45% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of SK Chemicals Co Ltd (285130)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For SK Chemicals Co Ltd it is 87,948 KRW per share (as of Sep 24, 2026), against a price of 51,800 KRW. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is SK Chemicals Co Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 285130 trades below its calculated fair value: price 51,800 KRW, fair value 87,948 KRW, a gap of about +70% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 285130?
No. The price is what the market pays today (51,800 KRW); the fair value is what the company's own numbers justify (87,948 KRW). For SK Chemicals Co Ltd the two are 36,148 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is SK Chemicals Co Ltd worth?
The market values SK Chemicals Co Ltd at about 892B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 51,800 KRW; our models calculate a fair value of 87,948 KRW per share.
What do the bullish and bearish scenarios say about 285130?
Our models span a range for SK Chemicals Co Ltd: cautious scenario 77,927 KRW, base 87,948 KRW, optimistic 87,948 KRW per share (as of Sep 24, 2026, price 51,800 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of SK Chemicals Co Ltd (285130)?
Balance-sheet figures for SK Chemicals Co Ltd (as of Sep 24, 2026): return on equity −0.6%, debt of 0.74 per unit of equity. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is 285130 from its 52-week high?
SK Chemicals Co Ltd trades at 51,800 KRW, about 34% below its 52-week high of 78,712 KRW and 39% above the low of 37,200 KRW (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 87,948 KRW is for.
Which stocks are comparable to SK Chemicals Co Ltd?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is SK Chemicals Co Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price 51,800 KRW, calculated fair value 87,948 KRW (+70%), Quality Score 39/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 285130 calculated?
We run SK Chemicals Co Ltd through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 87,948 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. SK Chemicals Co Ltd currently trades 41 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of SK Chemicals Co Ltd (285130)?
The closing price on Oct 2, 2026 was 51,800 KRW. Our model-based fair value is 87,948 KRW, about +70% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with SK Chemicals Co Ltd right now?
The large discount to fair value meets weak quality (39/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (77,927 KRW). The market is more pessimistic than our downside scenario. The models converge in a tight band (77,927 KRW to 87,948 KRW), unusually little disagreement for a valuation.
Key figures of SK Chemicals Co Ltd
How large is the market capitalisation of SK Chemicals Co Ltd (285130)?
The market capitalisation of SK Chemicals Co Ltd is 892B KRW (≈ $665M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of SK Chemicals Co Ltd (285130)?
The price-to-sales ratio of SK Chemicals Co Ltd is 0.32 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of SK Chemicals Co Ltd (285130)?
The dividend yield of SK Chemicals Co Ltd is 1.4% (payout 32.6%, on adjusted earnings, reported 29.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of SK Chemicals Co Ltd (285130)?
The net margin of SK Chemicals Co Ltd is 1.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of SK Chemicals Co Ltd (285130)?
The return on equity (ROE) of SK Chemicals Co Ltd is −0.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of SK Chemicals Co Ltd (285130)?
On an EBIT basis the return on assets of SK Chemicals Co Ltd is 4.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of SK Chemicals Co Ltd (285130)?
The operating margin of SK Chemicals Co Ltd is −2.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at SK Chemicals Co Ltd (285130)?
Revenue at SK Chemicals Co Ltd is growing +22.2% versus a year earlier (3y avg +8.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at SK Chemicals Co Ltd (285130)?
Earnings per share at SK Chemicals Co Ltd are growing +22.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does SK Chemicals Co Ltd (285130) generate?
The free cash flow of SK Chemicals Co Ltd is −230B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does SK Chemicals Co Ltd (285130) carry?
The net debt of SK Chemicals Co Ltd is 1.6T KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch SK Chemicals Co Ltd in the live analysis
One click puts SK Chemicals Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.